NEW 2017 COURSE PROGRAMME
This intensive course explores current opportunities made possible by the legislation, advances in information technology and new scientific methodology to enhance and modernise the approaches in the product lifecycle management.
The course starts with the current regulatory thinking about the Benefit-Risk methodology, including the relevant projects of the European Medicines Agency (EMA) / Committee for Medicinal Products for Human Use (CHMP). It gives a basis for the second part of the course, exploring the new European Benefit-Risk management planning – a notion stemming from the experience gathered over the past ten years with the EU Risk Management Plans (EU-RMPs). Participants will learn how to take advantage of the efficacy follow-up options given by the EU law and guidelines. A practical training in solving key aspects of the Benefit-Risk management based on real-life examples is included.
Participants will be provided with preparatory material in order to better participate at the group exercises onsite.
"Very professional lectors, life-based patterns, high professional attitude from lectors."
Dr. Uldis Armanis, Head of Pharmacovigilance Group, QPPV, JSC Olainfarml
Have an account?